Cargando…

Modulating gut immunity and neoplasia with oral cytokine adjuvants

Oral administration of particulate IL-10 suppressed polyposis, ameliorated systemic pathology and extended lifespan in APC(min/+) mice. Therapeutic effect was associated with selective activity of IL-10 on intestinal CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells. Studies were recently extende...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozbilge, Hatice, LeVea, Charles, Chung, Allen Y, Li, Qingsheng, Egilmez, Nejat K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485710/
https://www.ncbi.nlm.nih.gov/pubmed/26137401
http://dx.doi.org/10.1080/2162402X.2014.1002724
_version_ 1782378811236548608
author Ozbilge, Hatice
LeVea, Charles
Chung, Allen Y
Li, Qingsheng
Egilmez, Nejat K
author_facet Ozbilge, Hatice
LeVea, Charles
Chung, Allen Y
Li, Qingsheng
Egilmez, Nejat K
author_sort Ozbilge, Hatice
collection PubMed
description Oral administration of particulate IL-10 suppressed polyposis, ameliorated systemic pathology and extended lifespan in APC(min/+) mice. Therapeutic effect was associated with selective activity of IL-10 on intestinal CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells. Studies were recently extended to a bacterially-driven murine colon adenocarcinoma model with similar results. Clinical implications of these findings are discussed.
format Online
Article
Text
id pubmed-4485710
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-44857102016-01-22 Modulating gut immunity and neoplasia with oral cytokine adjuvants Ozbilge, Hatice LeVea, Charles Chung, Allen Y Li, Qingsheng Egilmez, Nejat K Oncoimmunology Author's View Oral administration of particulate IL-10 suppressed polyposis, ameliorated systemic pathology and extended lifespan in APC(min/+) mice. Therapeutic effect was associated with selective activity of IL-10 on intestinal CD4+Foxp3+RORγt+IL-17+ pathogenic T-regulatory cells. Studies were recently extended to a bacterially-driven murine colon adenocarcinoma model with similar results. Clinical implications of these findings are discussed. Taylor & Francis 2015-01-22 /pmc/articles/PMC4485710/ /pubmed/26137401 http://dx.doi.org/10.1080/2162402X.2014.1002724 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Author's View
Ozbilge, Hatice
LeVea, Charles
Chung, Allen Y
Li, Qingsheng
Egilmez, Nejat K
Modulating gut immunity and neoplasia with oral cytokine adjuvants
title Modulating gut immunity and neoplasia with oral cytokine adjuvants
title_full Modulating gut immunity and neoplasia with oral cytokine adjuvants
title_fullStr Modulating gut immunity and neoplasia with oral cytokine adjuvants
title_full_unstemmed Modulating gut immunity and neoplasia with oral cytokine adjuvants
title_short Modulating gut immunity and neoplasia with oral cytokine adjuvants
title_sort modulating gut immunity and neoplasia with oral cytokine adjuvants
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485710/
https://www.ncbi.nlm.nih.gov/pubmed/26137401
http://dx.doi.org/10.1080/2162402X.2014.1002724
work_keys_str_mv AT ozbilgehatice modulatinggutimmunityandneoplasiawithoralcytokineadjuvants
AT leveacharles modulatinggutimmunityandneoplasiawithoralcytokineadjuvants
AT chungalleny modulatinggutimmunityandneoplasiawithoralcytokineadjuvants
AT liqingsheng modulatinggutimmunityandneoplasiawithoralcytokineadjuvants
AT egilmeznejatk modulatinggutimmunityandneoplasiawithoralcytokineadjuvants